Cargando…
PTEN inhibitor VO-OHpic suppresses TSC2(-)(/)(-) MEFs proliferation by excessively inhibiting autophagy via the PTEN/PRAS40 pathway
Tuberous sclerosis complex (TSC) is a relatively rare autosomal dominant disease which involves multiple organs, including the brain, kidney, lung, skin and heart. Renal angiomyolipomas (RAML) are the main causes of mortality in patients with TSC. The preferred treatment for RAML is the use of mTOR...
Autores principales: | Wang, Wenda, Wang, Xu, Guo, Hao, Cai, Yi, Zhang, Yushi, Li, Hanzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185083/ https://www.ncbi.nlm.nih.gov/pubmed/32346419 http://dx.doi.org/10.3892/etm.2020.8629 |
Ejemplares similares
-
PTEN inhibitor VO-OHpic protects endplate chondrocytes against apoptosis and calcification via activating Nrf-2 signaling pathway
por: Cui, Xingang, et al.
Publicado: (2023) -
PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway
por: Yao, Xudong, et al.
Publicado: (2020) -
mTOR/PRAS40 interaction: Hypertrophy or proliferation
por: Völkers, Mirko, et al.
Publicado: (2013) -
Neurovascular Development in Pten and Tsc2 Mouse Mutants
por: Dusing, Mary, et al.
Publicado: (2023) -
PRAS40 signaling in tumor
por: Lv, Dan, et al.
Publicado: (2017)